That's not entirely fair. The other view: Oxford University pairs with a company with the global logistics and manufacturing capability to create billions of va

That's not entirely fair. The other view: Oxford University pairs with a company with the global logistics and manufacturing capability to create billions of vaccine in record time. I much prefer the idea of a royalty-free vaccine open to all, but I also understand the more practical route of working with a company if it means faster delivery where time is of the essence. The article posted here purposefully omits the cost price of the Oxford vaccine which is approximately £3 ($5). Even if AstraZeneca were to add a profit margin of a few dollars to the cost price (e.g. bring the cost to $10) that would still be cheaper than the vaccines from Biotech/Pfizer and Moderna. Also, Oxford has always insited that they wanted to create a vaccine that would be as cheap as possible to manufacture so it would be affordable to treat people around the world.